Your Genes May Determine Your Covid-19 Risk
November 10, 2020 | Emily Mullin
One company, GoodCell, based in Waltham, Massachusetts, is developing a commercial genetic test to predict a person’s risk of Covid-19 severity. The medical diagnostics company is working with the New York Blood Center to compare blood samples from healthy people and those who had mild or severe Covid-19. The results of the study will guide the design of a genetic test, says Salvatore Viscomi, MD, the company’s chief medical officer.